Showing results (11-20 of 766) with videos related to
Sort By:
Pageof 77
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1990
Pharmacokinetics and dynamics of furosemide in the newborn pigletJ J Miceli, P A Kramer, D J Chapron, et al.Journal of Clinical Psychopharmacology|June 1, 1982
Estimating steady state desipramine levels in noninstitutionalized elderly patients using single dose disposition parametersE J Antal, I R Lawson, L M Alderson, et al.Developmental Pharmacology and Therapeutics|January 1, 1990
Renal response to furosemide in very low birth weight infants during chronic administrationM H Mirochnick, J J Miceli, P A Kramer, et al.Journal of Clinical Psychopharmacology|February 1, 1982
Imipramine disposition in alcoholicsD A Ciraulo, L M Alderson, D J Chapron, et al.Clinical Pharmacology and Therapeutics|November 1, 1986
Toxic interaction between acetazolamide and salicylate: case reports and a pharmacokinetic explanationK R Sweeney, D J Chapron, J L Brandt, et al.The Annals of Pharmacotherapy|September 1, 1995
Lymphopenic effect of carbamazepine in a patient with chronic lymphocytic leukemiaD A Silverman, D J ChapronJournal of Clinical Pharmacology|November 1, 1992
Elucidating the relationship between acetazolamide plasma protein binding and renal clearance using an albumin infusionI H Gomolin, D J ChapronJournal of Pharmaceutical Sciences|July 1, 1984
Determination of acetazolamide in biological fluids by reverse-phase high-performance liquid chromatographyD J Chapron, L B WhiteArchives of Internal Medicine|March 1, 1979
Apparent quinidine-induced digoxin toxicity after withdrawal of pentobarbital: a case of sequential drug interactionsD J Chapron, D Mumford, G I PitegoffThe Annals of Pharmacotherapy|June 1, 1993
Unmasking the significant enzyme-inducing effects of phenytoin on serum carbamazepine concentrations during phenytoin withdrawalD J Chapron, B A LaPierre, M Abou-ElkairPageof 77